WHO Home
WHO Health Systems and Services
WHO Medicines
WHO sites
Medicines Documentation home
Search
Titles A-Z
Subjects
Keywords
Series and Periodicals
Publishers
Authors A-Z
Regions
Countries
Index
A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

F  
Factors affecting adherence and interventions used to improve it
Family, community and patients' organizations
Fighting poor-quality drugs
Financing drugs in South-East Asia
Fixed-dose combinations for HIV/AIDS, tuberculosis, and malaria
Free samples of prescription drugs
Full training in acupuncture for qualified physicians

 
 Top of page
G  
General guidelines for methodologies on research and evaluation of traditional medicine
General guidelines for the establishment, maintenance, and distribution of chemical reference substances
General recommendations for the preparation and use of infrared spectra in pharmaceutical analysis
Generic medicines: old problems and new challenges from a European perspective
Getting medicines to the people
Getting the message across: communications and pharmacovigilance
Global Adherence Interdisciplinary Network (GAIN)
Global and national efforts to reduce tobacco use
Globalization and access to drugs: implications of the WTO/TRIPS agreement
Good laboratory practices in governmental drug control laboratories
Good manufacturing practice (GMP)
Good pharmaceutical trade and distribution practices
Good practices in production and quality control
The graphic representation of chemical formulae in the publications of International Nonproprietary Names (INN)
Guide for data collection to assess drug regulatory performance
Guide to drug financing mechanisms
Guide to good prescribing
Guide to good storage practices for pharmaceuticals
Guidelines for clinical research on acupuncture
Guidelines for drug donations
Guidelines for evaluating an essential drugs programme
Guidelines for Good Clinical Practice (GCP) for trials on pharmaceutical products
Guidelines for stability testing of pharmaceutical products
Guidelines for the appropriate use of herbal medicines
Guidelines for the compilation of a product dossier
Guidelines for the establishment, maintenance and distribution of chemical reference substances
Guidelines for the management of sexually transmitted infections
Guidelines for the manufacture of herbal medicinal products
Guidelines for the regulatory assessment of medicinal products for use in self-medication
Guidelines for the storage of essential medicines
Guidelines for toxicity investigation of herbal medicines
Guidelines for training traditional health practitioners in primary health care
Guidelines on basic training and safety in acupuncture
Guidelines on import procedures for pharmaceutical products
Guidelines on the use of international nonproprietary names (INNs) for pharmaceutical substances
Guiding principles for small national drug regulatory authorities
Gynaecological and obstetric disorders

 
 Top of page
H  
Handbook on access to HIV/AIDS-related treatment
Handling of and accountability for pharmaceutical products
Harmonization of undergraduate pharmacy curricula in Southern and Eastern Africa
Health economics - the Uruguay round and drugs
Health insurance systems and access to medicines
Heating ventilation and air conditioning (HVAC)
Herbal medicinal products
Herpes and HIV co-infection
Historical development of drug regulation
A historical overview of the ATC/DDD methodology
HIV treatment guidelines for adults and adolescents
Home-use test kits
How can improved adherence be translated into health and economic benefits?
How does poor adherence affect policy-makers and health managers?
How frequently does the national formulary need to be reviewed?
How is TRIPS affecting access to medicines?
How to develop a national formulary based on the WHO model formulary
How to develop and implement a national drug policy
How to implement a policy on drug donations
How to implement computer-assisted drug registration
How to investigate drug use in health facilities
How to investigate the use of medicines by consumers
How to keep up-to-date about drugs
How to study medicines use in communities
Human immunodeficiency virus and acquired immunodeficiency syndrome
Human resources development
Human rights and access to drugs

 
 Top of page
I  
Illicit pharmaceutical markets
Immunization safety: a global priority
Impact of a short course in pharmacotherapy for undergraduate medical students
The impact of implementation of ICH guidelines in non-ICH countries
The impact of poor adherence
Implications for the development, production and marketing of drugs
Implications of the Doha declaration on the Trips agreement
Importance of legislation and regulations
The importance of pharmacovigilance
Improving adherence rates: guidance for countries
Improving international drug monitoring
Improving medicines use in hospitals
Increase the efficiency of available drugs
Increasing access to essential drugs through health insurance and drug financing
The increasing importance of self-care and self-medication
Indicators for injection use and for assessment of hygienic practices
Information for patients: package inserts, leaflets and booklets
Information on the INN programme
Injection practices in the developing world
Injections and specific illness conditions
Innovation and regulation in the pharmaceutical market
Inspection and examination of counterfeit pharmaceuticals
Inspection of drug distribution channels
Inspection of establishments in the drug distribution chain
Inspection when pharmaceutical products are suspected to be counterfeit, spurious or substandard
Integrated drug supply management and drug use monitoring and supervision
Integrating public health concerns into patent legislation in developing countries
Intercountry workshop on national drug policy
International comparisons of prices for a sample of medicines
The International Conference for Drug Regulatory Authorities
The International Conference on Harmonisation (ICH)
International Conference on Harmonization (ICH) Guidelines
International drug price indicator guide
The international innovative pharmaceutical industry's perspective (IFPMA)
The international pharmacopoeia and related activities
Introducing the gender perspective in national essential drug programmes
Investigational pharmaceutical products for clinical trials in humans
Involvement of traditional health practitioners in national AIDS programmes

 
 Top of page
 

Contacts | E-mail scams | Employment | FAQs | Feedback | Privacy | RSS feeds
© WHO 2013
Last updated: May 3, 2013